Heart failure and chronic obstructive pulmonary disease: An ignored combination?

被引:205
作者
Rutten, Frans H.
Cramer, Maarten-Jan M.
Lammers, Jan-Willem J.
Grobbee, Diederick E.
Hoes, Arno W.
机构
[1] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, UHFO, NL-3508 AB Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Cardiol, Heart Lung Ctr Utrecht, Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Pulm Dis, Heart Lung Ctr Utrecht, Utrecht, Netherlands
关键词
heart failure; chronic obstructive pulmonary disease; prevalence; review;
D O I
10.1016/j.ejheart.2006.01.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To quantify the prevalence of heart failure and left ventricular systolic dysfunction (LVSD) in chronic obstructive pulmonary disease (COPD) patients and vice versa. Further, to discuss diagnostic and therapeutic implications of the co-existence of both syndromes. Methods and results: We performed a Medline search from 1966 to March 2005. The reported prevalence of LVSD among COPD patients varied considerably, with the highest prevalence (10-46%) among those with an exacerbation. One single study assessed the prevalence of heart failure in COPD patients. A prevalence of 21% of previously unknown heart failure was reported in patients with a history of COPD or asthma. We did not find any report on COPD in heart failure or LVSD patients. Diagnosing heart failure in COPD patients or vice versa is complicated by overlap in signs and symptoms, and diminished diagnostic value of additional investigations. In general, pulmonary and heart failure 'drug cocktails' can be administered safely to patients with concomitant COPD and heart failure, although (short acting) beta-adrenoreceptor agonists and digitalis have potentially deleterious effects on cardiac and pulmonary function, respectively. Conclusion: Although knowledge about the prevalence of concomitant heart failure in COPD patients and vice versa is scarce, it seems that the combined presence is rather common. In view of diagnostic and therapeutic implications, more attention should be paid to the concomitant presence of both syndromes in clinical practice and research. (c) 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:706 / 711
页数:6
相关论文
共 50 条
[1]   Spironolactone improves lung diffusion in chronic heart failure [J].
Agostoni, P ;
Magini, A ;
Andreini, D ;
Contini, M ;
Apostolo, A ;
Bussotti, M ;
Cattadori, G ;
Palermo, P .
EUROPEAN HEART JOURNAL, 2005, 26 (02) :159-164
[2]   Dyspnea differentiation index - A new method for the rapid separation of cardiac vs pulmonary dyspnea [J].
Ailani, RK ;
Ravakhah, K ;
DiGiovine, B ;
Jacobsen, G ;
Tun, T ;
Epstein, D ;
West, BC .
CHEST, 1999, 116 (04) :1100-1104
[3]  
Aronow Wilbert S, 2003, Congest Heart Fail, V9, P142, DOI 10.1111/j.1527-5299.2003.01388.x
[4]   Risk of mortality and heart failure exacerbations associated with inhaled β-adrenoceptor agonists among patients with known left ventricular systolic dysfunction [J].
Au, DH ;
Udris, EM ;
Fan, VS ;
Curtis, JR ;
McDonell, MB ;
Fihn, SD .
CHEST, 2003, 123 (06) :1964-1969
[5]   ASSESSMENT OF CARDIAC-PERFORMANCE WITH QUANTITATIVE RADIONUCLIDE ANGIOCARDIOGRAPHY - RIGHT VENTRICULAR EJECTION FRACTION WITH REFERENCE TO FINDINGS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
BERGER, HJ ;
MATTHAY, RA ;
LOKE, J ;
MARSHALL, RC ;
GOTTSCHALK, A ;
ZARET, BL .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (05) :897-905
[6]   The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Moher, D ;
Rennie, D ;
de Vet, HCW ;
Lijmer, JG .
CLINICAL CHEMISTRY, 2003, 49 (01) :7-18
[7]   Left atrial and ventricular filling in chronic obstructive pulmonary disease - An echocardiographic and Doppler study [J].
Boussuges, A ;
Pinet, C ;
Molenat, F ;
Burnet, H ;
Ambrosi, P ;
Badier, M ;
Sainty, JM ;
Orehek, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :670-675
[8]   A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease [J].
Casaburi, R ;
Mahler, DA ;
Jones, PW ;
Wanner, A ;
San Pedro, G ;
ZuWallack, RL ;
Menjoge, SS ;
Serby, CW ;
Witek, T .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) :217-224
[9]   Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia [J].
Cazzola, M ;
Imperatore, F ;
Salzillo, A ;
Di Perna, F ;
Calderaro, F ;
Imperatore, A ;
Matera, MG .
CHEST, 1998, 114 (02) :411-415
[10]   QUANTITATIVE LEFT-VENTRICULAR CINEANGIOGRAPHY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
CHRISTIANSON, LC ;
SHAH, A ;
FISHER, VJ .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (03) :399-404